BTAI - BioXcel Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BTAI is currently covered by 4 analysts with an average price target of $58.63. This is a potential upside of $55.85 (2008.99%) from yesterday's end of day stock price of $2.78.

BioXcel Therapeutics's activity chart (see below) currently has 109 price targets and 99 ratings on display. The stock rating distribution of BTAI is 77.78% BUY, 11.11% SELL and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.27% with an average time for these price targets to be met of 316.8 days.

Highest price target for BTAI is $10, Lowest price target is $4, average price target is $6.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 14-Sep-2025. First documented stock forecast 01-Apr-2018.

Currently out of the existing stock ratings of BTAI, 7 are a BUY (77.78%), 1 are a SELL (11.11%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$10

$7.47 (295.26%)

$10

25 days ago
(14-Sep-2025)

6/22 (27.27%)

$6.83 (215.46%)

564

Hold

$4

$1.47 (58.10%)

$16

28 days ago
(11-Sep-2025)

7/11 (63.64%)

$0.89 (28.62%)

48

Sell

$4

$1.47 (58.10%)

$23

9 months 3 days ago
(06-Jan-2025)

4/4 (100%)

$-3.54 (-46.95%)

378

Buy

9 months 4 days ago
(05-Jan-2025)

9/11 (81.82%)

$-52.4 (-74.43%)

446

Hold

$16

$13.47 (532.41%)

$56

1 years 2 months 1 days ago
(08-Aug-2024)

2/6 (33.33%)

$4.3 (36.75%)

305

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTAI (BioXcel Therapeutics) average time for price targets to be met?

On average it took 316.8 days on average for the stock forecasts to be realized with a an average price target met ratio 65.27

Which analyst has the current highest performing score on BTAI (BioXcel Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on BTAI (BioXcel Therapeutics)?

Raghuram Selvaraju has 3 price targets and 17 ratings on BTAI

Which analyst is the currently most bullish on BTAI (BioXcel Therapeutics)?

Do Kim with highest potential upside - $1661.47

Which analyst is the currently most reserved on BTAI (BioXcel Therapeutics)?

Sumant Kulkarni with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?